Artificial intelligence–based prediction of metabolic dysfunction–associated steatotic liver disease (MASLD) and liver fibrosis in patients with obstructive sleep apnea: An innovative approach
Background Obstructive sleep apnea (OSA) is strongly associated with metabolic dysfunction and may contribute to the development of hepatic disorders such as metabolic dysfunction-associated steatotic liver disease (MASLD) and liver fibrosis. Early identification of hepatic involvement in OSA is important for preventin...